In fiscal year 2025, MedPacto (235980) reported revenue of 3.9 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 3.9 billion KRW | -14.0 billion KRW | -12.8 billion KRW | [source] |
| 2024 | — | -21.8 billion KRW | -20.1 billion KRW | [source] |
| 2023 | — | -28.8 billion KRW | -35.3 billion KRW | [source] |
| 2022 | — | -37.2 billion KRW | -35.8 billion KRW | [source] |
| 2021 | — | -29.5 billion KRW | -17.0 billion KRW | [source] |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 48.7 billion KRW | 2.7 billion KRW | 46.0 billion KRW | [source] |
| 2024 | 58.9 billion KRW | 1.2 billion KRW | 57.7 billion KRW | [source] |
| 2023 | 78.9 billion KRW | 8.0 billion KRW | 70.9 billion KRW | [source] |
| 2022 | 105.5 billion KRW | 73.2 billion KRW | 32.3 billion KRW | [source] |
| 2021 | 133.3 billion KRW | 89.8 billion KRW | 43.5 billion KRW | [source] |
This company has no revenue account in the DART financial statements. Industry-specific accounts such as insurance or interest income are not converted to revenue.